Dopaminergic dynamics underlying sex-specific cocaine reward

Erin S Calipari, Barbara Juarez, Carole Morel, Deena M Walker, Michael E Cahill, Efrain Ribeiro, Ciorana Roman-Ortiz, Charu Ramakrishnan, Karl Deisseroth, Ming-Hu Han, Eric J Nestler, Erin S Calipari, Barbara Juarez, Carole Morel, Deena M Walker, Michael E Cahill, Efrain Ribeiro, Ciorana Roman-Ortiz, Charu Ramakrishnan, Karl Deisseroth, Ming-Hu Han, Eric J Nestler

Abstract

Although both males and females become addicted to cocaine, females transition to addiction faster and experience greater difficulties remaining abstinent. We demonstrate an oestrous cycle-dependent mechanism controlling increased cocaine reward in females. During oestrus, ventral tegmental area (VTA) dopamine neuron activity is enhanced and drives post translational modifications at the dopamine transporter (DAT) to increase the ability of cocaine to inhibit its function, an effect mediated by estradiol. Female mice conditioned to associate cocaine with contextual cues during oestrus have enhanced mesolimbic responses to these cues in the absence of drug. Using chemogenetic approaches, we increase VTA activity to mechanistically link oestrous cycle-dependent enhancement of VTA firing to enhanced cocaine affinity at DAT and subsequent reward processing. These data have implications for sexual dimorphism in addiction vulnerability and define a mechanism by which cellular activity results in protein alterations that contribute to dysfunctional learning and reward processing.

Figures

Figure 1. Oestrus-conditioned female mice exhibit elevated…
Figure 1. Oestrus-conditioned female mice exhibit elevated CPP for cocaine and enhanced basal reward circuit function.
(a) Timeline of cocaine CPP experiments. (b) Representative heat maps of time spent in each area of the CPP chamber for male (left), oestrus-conditioned females (centre) and dioestrus-conditioned females (right). (c) Increased CPP in females was only observed in mice paired with cocaine conditioning during oestrus (one-way analysis of variance (ANOVA); F(2, 12)=13.13, P<0.001; **P<0.01 oestrus versus dioestrus, ##P<0.01 oestrus versus male). (d) Electrophysiological traces showing increased phasic activity of VTA dopamine neurons in oestrus females. In vivo single-unit electrophysiology of basal activity of putative VTA dopamine neurons identified increased: (e) firing rate (Kruskal–Wallis (KW) (χ2(2)=11.76, P<0.005; *P<0.05, ###P<0.001), (f) percentage of spikes within burst (one-way ANOVA F(2, 36)=7.858, P<0.005; */#P<0.05) and (g) burst length (KW (χ2(2)=10.17, P<0.01; *P<0.05, ###P<0.001) in only oestrus females when compared with males (#) or dioestrus females (*). (h) FSCV recordings of subsecond dopamine release in the NAc. (i) Current versus time plots (left) and colour plots showing the presence of dopamine after one pulse tonic stimulation, as indicated by its oxidation at +0.6 V and reduction at −0.2 V. (j) Current versus time plots showing increased dopamine release to increasing frequency of five pulse stimulations. (k) Group data showing enhanced NAc dopamine per one pulse tonic stimulation in oestrus females (one-way ANOVA; F(2, 6)=11.57; *P<0.05, #P<0.05). (l) Phasic responsivity was increased in oestrus females (two-way ANOVA; F(6, 18)=3.279, P<0.05; *P<0.05, #P<0.05). (m) Phasic responses represented as a percent of one pulse (tonic) release. Oestrus females exhibit increased dopamine release during phasic stimulations (two-way ANOVA; F(3, 14)=9.079, P<0.05; *P<0.05, #P<0.05). *P<0.05, **P<0.01, ***P<0.001 oestrus versus dioestrus (unless otherwise noted); #P<0.05, ##P<0.01 oestrus versus male. Data represented as mean±s.e.m.
Figure 2. Oestrus females exhibit enhanced cocaine…
Figure 2. Oestrus females exhibit enhanced cocaine actions on the VTA-NAc reward pathway.
(a) Timeline of CPP and paired fibre photometry recordings. (b) Schematic of fibre photometry recording experiments for VTA recordings during conditioning sessions. (c) Representative Ca2+ imaging traces from male, oestrus female and dioestrus female mice during saline (left) and cocaine (right) conditioning. (d) Cocaine reduces frequency of VTA Ca2+ events (two-way analysis of variance (ANOVA); F(2, 8)=5.792, P<0.05; *P<0.05 as compared with saline). (e) Cocaine-induced frequency reductions in activity were greater during oestrus (one-way ANOVA; F(2, 8)=23.76, P<0.001; ***, P<0.001, ##P<0.01) when compared with males (#) or dioestrus females (*). (f) Cocaine-induced changes in the amplitude of Ca2+ events (two-way ANOVA; F(1, 10)=25.53, P<0.001; ***P<0.001 versus saline). (g) Correlation between percent change in frequency activity of VTA neurons and CPP (r=0.9445; P<0.0001). (h) Schematic of FSCV recordings with bath application of cocaine performed in NAc slices (right) and representative current versus time plots showing cocaine (10 μM) effects on one pulse evoked dopamine release (left). (i) Current versus time plot (left) and colour plots (right) showing the presence of dopamine, as indicated by its oxidation at +0.6 V and reduction at −0.2 V, and the effects of bath application of 10 μM cocaine. (j) Concentration–response curves show that cocaine potency is increased selectively in females during oestrus with no difference in baseline activity (two-way ANOVA; F(4, 16)=15.73, P<0.0001; *P<0.05, ****P<0.0001, #P<0.05, ####P<0.0001). (k) Ki values show that the affinity of cocaine for DAT is increased during oestrus (one-way ANOVA; F(2, 6)=6.564, P<0.05; *P<0.05). (l) Serum estradiol levels were increased during oestrus (one-way ANOVA; F(2, 13)=4.83, P<0.05; *P<0.05). (m) Serum estradiol levels taken immediately before FSCV recordings was positively correlated with cocaine potency (r=0.731; P<0.01). (n) Western blot analysis showing that dopamine transporter levels are not changed over the oestrous cycle (one-way ANOVA F(2, 21)=0.68, P=0.52) (top), yet levels of the phosphorylated Thr53 site on the dopamine transporter were increased during oestrus (one-way ANOVA F(2, 21)=0.37, P<0.05; #P<0.05) (bottom). (o) Total ERK levels were not changed between groups (one-way ANOVA F(2, 21)=0.01, P=0.99) (top), whereas phosphorylated ERK levels were increased significantly during oestrus (one-way ANOVA F(2, 21)=3.97, P<0.05; *P<0.05) (bottom). (p) These increased phospho ERK levels were correlated with DAT Thr53 phosphorylation (r=0.47, P<0.05). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 oestrus versus dioestrus (unless otherwise noted); #P<0.05, ##P<0.01, ###P<0.001, ####P<0.0001 oestrus versus male. Data represented as mean±s.e.m.
Figure 3. Cocaine-conditioned oestrus females exhibit enhanced…
Figure 3. Cocaine-conditioned oestrus females exhibit enhanced VTA and NAc responses to cocaine-associated cues.
(a) Timeline of CPP experiments and paired fibre photometry recordings during choice test 24 h after the last conditioning session. (b) Schematic of recording experiments for VTA cell body recordings, which were taken during the choice test, 24 h after the last conditioning session. (c) Representative VTA Ca2+ activity trace during choice test demonstrating increases in activity preceding entry (dashed line) into the drug-paired (blue) chamber (left); averaged Ca2+ activity in a 10 s window around paired chamber entry (right). (d) The amplitude (ΔF/F) of the spike in Ca2+ activity preceding cocaine-paired chamber entry was increased in oestrus-conditioned female mice (one-way analysis of variance (ANOVA); F(2, 9)=6.603, P<0.05; *P<0.05; #P<0.05) when compared with males (#) or dioestrus females (*). (e) Heat maps of Ca2+ activity over time during successive entries (rows) into the cocaine-paired chamber across groups. (f) Correlation between the amplitude of VTA response to the cocaine-paired context and preference score for cocaine (r=0.881; P<0.0001). (g) Schematic of recording experiments for NAc recordings taken at the same time as VTA recordings during the choice test 24 h after the last conditioning session. (h) Representative Ca2+ activity trace, from the same animal as depicted in c, showing VTA terminal activity in the NAc around cocaine-paired (blue) and unpaired (red) entry where dashed lines denote entry into the cocaine-paired chamber (left); averaged Ca2+ activity in a 10 s window around paired chamber entry (right). (i) The amplitude of the spike in VTA terminal Ca2+ activity in NAc preceding cocaine-paired chamber entry was increased in oestrus-conditioned female mice (Kruskal–Wallis (KW); χ2 (2)=8.122, P<0.01; *P<0.05). (j) Heat maps of Ca2+ activity over time during successive entries (rows) into the cocaine-paired chamber across groups. (k) Correlation between the amplitude of VTA terminal Ca2+ activity in NAc to the cocaine-paired context and CPP for cocaine (r=0.883; P<0.0001). *P<0.05 versus dioestrus; #P<0.05 versus male. Data represented as mean±s.e.m.
Figure 4. Oestrous cycle-dependent fluctuations in VTA…
Figure 4. Oestrous cycle-dependent fluctuations in VTA and NAc are mediated by dopaminergic signalling.
(a) Timeline of CPP experiments and paired fibre photometry recordings during choice test 24 h after the last conditioning session. (b) Schematic of recording experiments for VTA cell body recordings in TH-BAC-Cre mice, which were taken during the saline or cocaine pairing. (c) Representative Ca2+ imaging traces from male (left), oestrus female (middle) and dioestrus female (right) mice during saline and cocaine conditioning. (d) Cocaine reduces the amplitude of VTA Ca2+ events (two-way analysis of variance (ANOVA); F(1, 8)=8.63, P<0.01; *P<0.05 as compared with saline). (e) Cocaine-induced amplitude reductions in activity were greater during oestrus (one-way ANOVA; F(2, 8)=23.76; *P<0.05) when compared with males or dioestrus females. (f) Schematic of recording experiments for VTA cell body and terminal recordings in TH-BAC-Cre mice, which were taken during the choice test, 24 h after the last conditioning session. (g) Left: representative VTA Ca2+ activity trace during choice test demonstrating increases in activity preceding entry (dashed line) into the drug-paired (blue). (g) Right: the area under the curve (ΔF/F) of the spike in Ca2+ activity preceding cocaine-paired chamber entry was increased in oestrus-conditioned female mice (one-way ANOVA; F(2, 8)=5.80, P<0.05; *P<0.05). (h) Left: representative NAc Ca2+ activity trace. (h) Right: the area under the curve (ΔF/F) of the spike in Ca2+ activity in NAc terminals preceding cocaine-paired chamber entry (one-way ANOVA; F(2, 8)=4.50, P<0.05). (i) Left: heat maps of VTA-dopamine Ca2+ activity over time during successive entries (rows) into the cocaine-paired chamber across groups. (i) Right: averaged VTA-dopamine Ca2+ activity in a window around paired chamber entry. (j) Left: heat maps of NAc terminal-dopamine Ca2+ activity over time during successive entries. (j) Right: averaged NAc terminal-dopamine Ca2+ activity in a window around paired chamber entry. Data represented as mean±s.e.m.
Figure 5. Enhancing VTA dopamine activity in…
Figure 5. Enhancing VTA dopamine activity in dioestrus females increases cocaine reward processing.
(a) Schematic of VTA firing through the oestrous cycle (top); experimental design using excitatory DREADDS (hM3Dq) expressed exclusively in dopamine neurons using TH-BAC-Cre mice to increase VTA dopamine activity (bottom). (b) Representative FSCV current versus time plots showing dopamine release to increasing frequency stimulations during oestrus, dioestrus or in males on the second day of vehicle or CNO injections. (c) Group data demonstrate enhanced dopamine per stimulation in dioestrus females and males that were given CNO to enhance VTA firing rates (one-way analysis of variance (ANOVA); F(5, 12)=3.78, P<0.05; *P<0.05). (d) Phasic responsivity was increased in dioestrus females and males given CNO (two-way ANOVA; F(5, 8)=3.93, P<0.05; *P<0.05. (e) Colour plots showing the presence of dopamine, as indicated by its oxidation at +0.6 V and reduction at −0.2 V, and the effects of bath application of 1, 3, 10 and 30 μM cocaine in each group. (f) Concentration–response curves showing that cocaine potency is increased in oestrus females and dioestrus females that were given CNO as compared with dioestrus controls. (g) Ki values showing that the affinity of cocaine for DAT is increased in dioestrus females and males given CNO (one-way ANOVA; F(5, 12)=3.89, P<0.05; *P<0.05). (h) Schematic of CPP experiments with CNO injections. (i) Increased CPP in male and dioestrus females with CNO+DREADDs to increase VTA firing (one-way ANOVA; F(5, 12)=3.78, P<0.05; *P<0.05 versus dioestrus). Data represented as mean±s.e.m.
Figure 6. Proposed schematic highlighting a potential…
Figure 6. Proposed schematic highlighting a potential mechanism for the activity-dependent changes in reward processing that occur during oestrus.
(1) The VTA to NAc pathway comprises dopaminergic neurons (purple) and other neuronal subpopulations (grey). (2) Dopamine neuron firing is enhanced during oestrus. (3) The increased activity of this pathway leads to downstream ERK activation and concomitant phosphorylation of Thr53 (blue) on DAT. (4) These changes in DAT lead to alterations in cocaine affinity, whereby cocaine is more able to bind to DAT and increase extracellular dopamine levels. This increased cocaine binding leads to increased dopamine levels in the NAc. (5) In vivo this drives increased associations between cocaine and contextual cues, which leads to enhanced cocaine CPP due to differences in the perceived rewarding value of cocaine.

References

    1. Reid A. G., Lingford-Hughes A. R., Cancela L. M. & Kalivas P. W. Substance abuse disorders. Handb. Clin. Neurol. 106, 419–431 (2012).
    1. Becker J. B. & Koob G. F. Sex differences in animal models: focus on addiction. Pharmacol. Rev. 68, 242–263 (2016).
    1. Van Etten M. L., Neumark Y. D. & Anthony J. C. Male-female differences in the earliest stages of drug involvement. Addiction 94, 1413–1419 (1999).
    1. Kasperski S. J. et al.. College students' use of cocaine: results from a longitudinal study. Addict. Behav. 36, 408–411 (2011).
    1. Randall C. L. et al.. Telescoping of landmark events associated with drinking: a gender comparison. J. Stud. Alcohol 60, 252–260 (1999).
    1. Chen K. & Kandel D. Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug Alcohol Depend. 68, 65–85 (2002).
    1. Brady K. T. & Randall C. L. Gender differences in substance use disorders. Psychiatr. Clin. North Am. 22, 241–252 (1999).
    1. Carpenter M. J., Upadhyaya H. P., LaRowe S. D., Saladin M. E. & Brady K. T. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob. Res. 8, 627–638 (2006).
    1. Ignjatova L. & Raleva M. Gender difference in the treatment outcome of patients served in the mixed-gender program. Bratisl. Lek. Listy 110, 285–289 (2009).
    1. Gallop R. J. et al.. Differential transitions between cocaine use and abstinence for men and women. J. Consult Clin. Psychol. 75, 95–103 (2007).
    1. Evans S. M. & Foltin R. W. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm. Behav. 58, 13–21 (2010).
    1. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P. R. & Hatsukami D. K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 7, 274–283 (1999).
    1. Evans S. M., Haney M. & Foltin R. W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159, 397–406 (2002).
    1. Arnold A. P. & Chen X. What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? Front. Neuroendocrinol. 30, 1–9 (2009).
    1. Carruth L. L., Reisert I. & Arnold A. P. Sex chromosome genes directly affect brain sexual differentiation. Nat. Neurosci. 5, 933–934 (2002).
    1. McCarthy M. M. & Arnold A. P. Reframing sexual differentiation of the brain. Nat. Neurosci. 14, 677–683 (2011).
    1. Becker J. B. & Cha J. H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 35, 117–125 (1989).
    1. Becker J. B., Robinson T. E. & Lorenz K. A. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur. J. Pharmacol. 80, 65–72 (1982).
    1. Walker Q. D. et al.. Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 25, 118–130 (2001).
    1. Humphries M. D. & Prescott T. J. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog. Neurobiol. 90, 385–417 (2010).
    1. Schultz W., Dayan P. & Montague P. R. A neural substrate of prediction and reward. Science 275, 1593–1599 (1997).
    1. Zhang D., Yang S., Yang C., Jin G. & Zhen X. Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine. Psychopharmacology (Berl) 199, 625–635 (2008).
    1. Phillips P. E., Stuber G. D., Heien M. L., Wightman R. M. & Carelli R. M. Subsecond dopamine release promotes cocaine seeking. Nature 422, 614–618 (2003).
    1. Cummings J. A., Jagannathan L., Jackson L. R. & Becker J. B. Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior. Drug Alcohol Depend. 135, 22–28 (2014).
    1. Di Chiara G. & Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274–5278 (1988).
    1. Gunaydin L. A. et al.. Natural neural projection dynamics underlying social behavior. Cell 157, 1535–1551 (2014).
    1. Cui G. et al.. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494, 238–242 (2013).
    1. Lacey M. G., Mercuri N. B. & North R. A. Actions of cocaine on rat dopaminergic neurones in vitro. Br. J. Pharmacol. 99, 731–735 (1990).
    1. Giros B. & Caron M. G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43–49 (1993).
    1. Juarez B. & Han M. H. Diversity of dopaminergic neural circuits in response to drug exposure. Neuropsychopharmacology 41, 2424–2446 (2016).
    1. Siciliano C. A., Calipari E. S., Ferris M. J. & Jones S. R. Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. ACS Chem. Neurosci. 6, 27–36 (2015).
    1. Ramamoorthy S., Shippenberg T. S. & Jayanthi L. D. Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol. Ther. 129, 220–238 (2011).
    1. Foster J. D. et al.. Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux. J. Biol. Chem. 287, 29702–29712 (2012).
    1. Moron J. A. et al.. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 8480–8488 (2003).
    1. Foster J. D. & Vaughan R. A. Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation. J. Biol. Chem. 286, 5175–5186 (2011).
    1. Gorentla B. K., Moritz A. E., Foster J. D. & Vaughan R. A. Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48, 1067–1076 (2009).
    1. Schmitt K. C. & Reith M. E. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. Ann. N. Y. Acad. Sci. 1187, 316–340 (2010).
    1. Vaughan R. A. & Foster J. D. Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol. Sci. 34, 489–496 (2013).
    1. Gerdjikov T. V., Ross G. M. & Beninger R. J. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav. Neurosci. 118, 740–750 (2004).
    1. Shi X. & McGinty J. F. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 138, 1289–1298 (2006).
    1. Schultz W. Behavioral theories and the neurophysiology of reward. Annu. Rev. Psychol. 57, 87–115 (2006).
    1. Calipari E. S. et al.. In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward. Proc. Natl Acad. Sci. USA 113, 2726–2731 (2016).
    1. Crombag H. S., Bossert J. M., Koya E. & Shaham Y. Review. Context-induced relapse to drug seeking: a review. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 3233–3243 (2008).
    1. Grimm J. W., Hope B. T., Wise R. A. & Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412, 141–142 (2001).
    1. O'Brien C. P., Childress A. R., McLellan A. T. & Ehrman R. Classical conditioning in drug-dependent humans. Ann. N. Y. Acad. Sci. 654, 400–415 (1992).
    1. Ehrman R. N., Robbins S. J., Childress A. R. & O'Brien C. P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) 107, 523–529 (1992).
    1. Volkow N. D., Fowler J. S., Wang G. J. & Swanson J. M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9, 557–569 (2004).
    1. Gong S. et al.. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J. Neurosci. 27, 9817–9823 (2007).
    1. Roth B. L. DREADDs for neuroscientists. Neuron 89, 683–694 (2016).
    1. Walker Q. D., Ray R. & Kuhn C. M. Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology 31, 1193–1202 (2006).
    1. Jackson L. R., Robinson T. E. & Becker J. B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 31, 129–138 (2006).
    1. Yang H., Zhao W., Hu M. & Becker J. B. Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration. Behav. Brain Res. 184, 174–184 (2007).
    1. Zhao W. & Becker J. B. Sensitization enhances acquisition of cocaine self-administration in female rats: estradiol further enhances cocaine intake after acquisition. Horm. Behav. 58, 8–12 (2010).
    1. Hu M. & Becker J. B. Acquisition of cocaine self-administration in ovariectomized female rats: effect of estradiol dose or chronic estradiol administration. Drug Alcohol Depend. 94, 56–62 (2008).
    1. Ha S. & Redmond L. ERK mediates activity dependent neuronal complexity via sustained activity and CREB-mediated signaling. Dev. Neurobiol. 68, 1565–1579 (2008).
    1. Wheeler R. A. & Carelli R. M. Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 56 (Suppl 1), 149–159 (2009).
    1. Koo J. W. et al.. BDNF is a negative modulator of morphine action. Science 338, 124–128 (2012).
    1. Ungless M. A. & Grace A. A. Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 35, 422–430 (2012).
    1. Morel C. et al.. Nicotine consumption is regulated by a human polymorphism in dopamine neurons. Mol. Psychiatry 19, 930–936 (2013).
    1. Yorgason J. T., Espana R. A. & Jones S. R. Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J. Neurosci. Methods 202, 158–164 (2011).

Source: PubMed

3
Abonnere